Literature DB >> 20922410

Warfarin embryopathy: fetal manifestations.

Helen Wainwright1, Peter Beighton.   

Abstract

During the period 1991-2007, autopsy was undertaken in 13 fetuses with warfarin embryopathy. Pregnancy data and radiographic babygrams were available in each instance. Gestational age ranged from 17 to 37 weeks. Eleven of the fetuses had the characteristic nasal hypoplasia, but only three had radiological epiphyseal stippling. Cerebral hemorrhage was a major feature of autopsy in 8 of the fetuses, and it is evident that bleeding is a significant factor in the pathogenesis of warfarin embryopathy. A wide variety of additional visceral manifestations which were observed at autopsy have been tabulated. There was no obvious correlation between maternal or gestational age and the presence and severity of any specific embryopathic feature. No information was available concerning the dose and timing of warfarin administration in this series.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20922410     DOI: 10.1007/s00428-010-0982-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  16 in total

1.  The risk of fetal loss associated with Warfarin anticoagulation.

Authors:  D Blickstein; I Blickstein
Journal:  Int J Gynaecol Obstet       Date:  2002-09       Impact factor: 3.561

2.  Lethal epiphyseal stippling in the foetus and neonate; pathological implications.

Authors:  Helen Wainwright; Peter Beighton
Journal:  Virchows Arch       Date:  2010-03       Impact factor: 4.064

3.  National population-based HIV surveys--the method of choice for measuring the HIV epidemic.

Authors:  Thomas Rehle; Olive Shisana
Journal:  S Afr Med J       Date:  2009-09

Review 4.  Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature.

Authors:  W S Chan; S Anand; J S Ginsberg
Journal:  Arch Intern Med       Date:  2000-01-24

5.  The growth of the nasal septum in the 6-9 week period of foetal development--Warfarin embryopathy offers a new insight into prenatal facial development.

Authors:  A M Howe; J K Hawkins; W S Webster
Journal:  Aust Dent J       Date:  2004-12       Impact factor: 2.291

Review 6.  Rheumatic and nonrheumatic valvular heart disease: epidemiology, management, and prevention in Africa.

Authors:  Mohammed Rafique Essop; Vuyisile T Nkomo
Journal:  Circulation       Date:  2005-12-06       Impact factor: 29.690

7.  Fetotoxicity of warfarin anticoagulation.

Authors:  Sumit Mehndiratta; Amita Suneja; Bindiya Gupta; Shuchi Bhatt
Journal:  Arch Gynecol Obstet       Date:  2010-01-29       Impact factor: 2.344

Review 8.  Neurological sequelae of intrauterine warfarin exposure.

Authors:  Sanjay Raghav; David Reutens
Journal:  J Clin Neurosci       Date:  2006-11-14       Impact factor: 1.961

9.  Pregnancy in women with prosthetic heart valves.

Authors:  P G Pieper; A Balci; A P Van Dijk
Journal:  Neth Heart J       Date:  2008-12       Impact factor: 2.380

10.  Anticoagulation of pregnant women with mechanical heart valves.

Authors:  Jeffrey S Ginsberg; Wee Shian Chan; Shannon M Bates; Scott Kaatz
Journal:  Arch Intern Med       Date:  2003-03-24
View more
  3 in total

1.  Low-dose warfarin maternal anticoagulation and fetal warfarin syndrome.

Authors:  Ana R Sousa; Rita Barreira; Edmundo Santos
Journal:  BMJ Case Rep       Date:  2018-04-07

2.  Warfarin-Associated Diaphragmatic Hernia: An Unusual Diagnosis.

Authors:  Cristina Vilhena; Cátia Gameiro; Cláudia Tomás; Antónia Santos; Raquel Ilgenfritz
Journal:  Case Rep Obstet Gynecol       Date:  2015-05-20

3.  Valvular heart disease during pregnancy: a clinical case and a literature review.

Authors:  Diana Bužinskienė; Gintautas Domža; Justyna Dulko; Miglė Olšauskaitė; Gražina Drąsutienė; Daina Liekienė
Journal:  Acta Med Litu       Date:  2018
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.